Healthcare professionals' level of medication knowledge in Africa: a systematic review

por Berhe, Derbew Fikadu, Taxis, Katja, Haaijer‐Ruskamp, Flora M., Mol, Peter G. M.
Publicado 2018

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations

por Mol, Peter G. M., Thompson, Aliza, Heerspink, Hiddo J. L., Leufkens, Hubert G. M.
Publicado 2018

Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study

por Roldan Munoz, Sonia, Lupattelli, Angela, de Vries, Sieta T, Mol, Peter G M, Nordeng, Hedvig
Publicado 2020

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making

por Bakker, Elisabeth, Plueschke, Kelly, Jonker, Carla J., Kurz, Xavier, Starokozhko, Viktoriia, Mol, Peter G. M.
Publicado 2022

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care

por Denig, Petra, van Puijenbroek, Eugène P., Soliman, Nashwa, Mol, Peter G. M., de Vries, Sieta T.
Publicado 2019

Future of the drug label: Perspectives from a multistakeholder dialogue

por Gispen‐de Wied, Christine C., Weemers, Just, Boon, Wouter, Mol, Peter G.M., Stolk, Pieter
Publicado 2019

Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine?

por Zijp, Tanja R., Mol, Peter G.M., Touw, Daan J., van Boven, Job F.M.
Publicado 2019

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

por de Vries, Sieta T., Denig, Petra, Ekhart, Corine, Mol, Peter G. M., van Puijenbroek, Eugene P.
Publicado 2020

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands

por de Vries, Esther, Bakker, Elisabeth, Monster, Taco B. M., Denig, Petra, Mol, Peter G. M.
Publicado 2022

Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020

por Bakker, Elisabeth, Starokozhko, Viktoriia, Kraaijvanger, Jet W. M., Heerspink, Hiddo J. L., Mol, Peter G. M.
Publicado 2023

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study

por de Vries, Sieta T., Wong, Lisa, Sutcliffe, Alastair, Houÿez, François, Ruiz, Carmen Lasheras, Mol, Peter G. M.
Publicado 2016

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe

por Koomen, Jeroen V., Stevens, Jasper, Monster-Simons, Margje H., Heerspink, Hiddo J. L., Mol, Peter G. M.
Publicado 2021

Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach

por de Vries, Esther, Bakker, Elisabeth, Francisca, Remy D. C., Croonen, Stijn, Denig, Petra, Mol, Peter G. M.
Publicado 2022

Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia

por Berhe, Derbew Fikadu, Taxis, Katja, Haaijer-Ruskamp, Flora M, Mulugeta, Afework, Mengistu, Yewondwossen Tadesse, Mol, Peter G M
Publicado 2017

The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products

por Smith, Meredith Y., Russell, Andrea, Bahri, Priya, Mol, Peter G. M., Frise, Sarah, Freeman, Emily, Morrato, Elaine H.
Publicado 2017

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients

por de Vries, Sieta T., Denig, Petra, Lasheras Ruiz, Carmen, Houÿez, François, Wong, Lisa, Sutcliffe, Alastair, Mol, Peter G. M.
Publicado 2018

Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry‐based study

por Jonker, Carla J., Oude Rengerink, Katrien, Hoes, Arno W., Mol, Peter G. M., van den Berg, H. Marijke
Publicado 2020

Registries supporting new drug applications

por Jonker, Carla J., van den Berg, H. Marijke, Kwa, Marcel S.G., Hoes, Arno W., Mol, Peter G.M.
Publicado 2017

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study

por de Vries, Sieta T., Denig, Petra, Ekhart, Corine, Burgers, Jako S., Kleefstra, Nanno, Mol, Peter G.M., van Puijenbroek, Eugène P.
Publicado 2019

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands

por de Vries, Esther, Denig, Petra, de Vries, Sieta T., Monster, Taco B. M., Hugtenburg, Jacqueline G., Mol, Peter G. M.
Publicado 2020